Just think… this time next year. We should be ap
Post# of 148175
(Total Views: 789)
Posted On: 08/30/2021 2:42:55 PM
Just think… this time next year. We should be approaching a 3 digit stock price. That’s when We should all buy some more of those 3 finger waving Nader shirts and coffee cups. In celebration of a prediction that Nader can own and claim. He deserves the accolades and everyone will know it by then.
With another year we finish a Nash and Cancer phase 3 trials that net us a quick fast tracked approvals for them both by years end or early 2023. We have already achieved and had the HIV submission and future approval by mid year 2022 that helped us gain recognition for our Covid EUA’s and one full approval should happen for all 3 indications by 4th quarter of the year also. 2022 is looking quite good. The future is blindingly bright.
While all this good news is happening we start our new 10 trials next year. These trials we start are some kind of basket trials for autoimmune diseases and prove that we are the quarterback of the immune system. This is why we don’t just do one indication at a time and that a basket trial for autoimmune diseases is appropriate for us. Basket trials prove to be our mantra after a successful cancer basket trial. Then we tackle another 9 life saving diseases besides the autoimmune basket trials to keep in pace with our future direction of our current managements plan of 10 indications trialed a year. ( our own big Pharma company).
This will be one heck of a magic carpet ride… I am totally ready for a little magic to take place.
Forgive me. I had to post something good to give us something to ponder and look forward to possibly. I know I am the true optimist. But what I am saying here is easy to see happen for me. The question is… can you see what I am seeing? It’s all good… good times are a coming. My cup runneth over but hey… it’s a full cup and looking good!
Of coarse this is my opinion. I could be wrong. Not likely though…. Wouldn’t a autoimmune basket trial just be awesome… there are over 100 autoimmune diseases according to American Autoimmune related diseases association,Inc. https://www.awards.org/
With another year we finish a Nash and Cancer phase 3 trials that net us a quick fast tracked approvals for them both by years end or early 2023. We have already achieved and had the HIV submission and future approval by mid year 2022 that helped us gain recognition for our Covid EUA’s and one full approval should happen for all 3 indications by 4th quarter of the year also. 2022 is looking quite good. The future is blindingly bright.
While all this good news is happening we start our new 10 trials next year. These trials we start are some kind of basket trials for autoimmune diseases and prove that we are the quarterback of the immune system. This is why we don’t just do one indication at a time and that a basket trial for autoimmune diseases is appropriate for us. Basket trials prove to be our mantra after a successful cancer basket trial. Then we tackle another 9 life saving diseases besides the autoimmune basket trials to keep in pace with our future direction of our current managements plan of 10 indications trialed a year. ( our own big Pharma company).
This will be one heck of a magic carpet ride… I am totally ready for a little magic to take place.
Forgive me. I had to post something good to give us something to ponder and look forward to possibly. I know I am the true optimist. But what I am saying here is easy to see happen for me. The question is… can you see what I am seeing? It’s all good… good times are a coming. My cup runneth over but hey… it’s a full cup and looking good!
Of coarse this is my opinion. I could be wrong. Not likely though…. Wouldn’t a autoimmune basket trial just be awesome… there are over 100 autoimmune diseases according to American Autoimmune related diseases association,Inc. https://www.awards.org/
(15)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼